94 related articles for article (PubMed ID: 392144)
1. [Management of autonomic disorders in amyloidosis].
Suzuki T
Nihon Rinsho; 1979 Sep; 37(9):3259-65. PubMed ID: 392144
[No Abstract] [Full Text] [Related]
2. [Treatment of orthostatic hypotension by noradrenaline supplement].
Hayashi A
No To Shinkei; 1985 Jul; 37(7):665-9. PubMed ID: 3933534
[No Abstract] [Full Text] [Related]
3. Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.
Suzuki T; Higa S; Sakoda S; Hayashi A; Yamamura Y; Takaba Y; Nakajima A
Neurology; 1981 Oct; 31(10):1323-6. PubMed ID: 6287350
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
[No Abstract] [Full Text] [Related]
5. Droxidopa in neurogenic orthostatic hypotension.
Kaufmann H; Norcliffe-Kaufmann L; Palma JA
Expert Rev Cardiovasc Ther; 2015; 13(8):875-91. PubMed ID: 26092297
[TBL] [Abstract][Full Text] [Related]
6. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
Ho AH; Kinter CW; Wight J; Neelam AR; Krakow D
J Med Case Rep; 2020 Jun; 14(1):73. PubMed ID: 32560740
[TBL] [Abstract][Full Text] [Related]
7. [A case with acute pandysautonomia with aseptic meningitis--Pathophysiological and therapeutic study].
Ushiyama M; Ikeda S; Yazawa M; Yanagisawa N; Takatsu M
Rinsho Shinkeigaku; 1987 Aug; 27(8):1035-42. PubMed ID: 3121228
[No Abstract] [Full Text] [Related]
8. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
Kaufmann H
Clin Auton Res; 2008 Mar; 18 Suppl 1():19-24. PubMed ID: 18368303
[TBL] [Abstract][Full Text] [Related]
9. [A case of diabetic orthostatic hypotension effectively managed with L-dops (L-threo-3,4-dihydroxyphenylserine)].
Yoshikawa H; Kawai K; Inoue S; Murayama Y; Kuzuya N; Fujita T; Koide Y; Yamashita K; Yoshizawa K; Mizusawa H
Nihon Naika Gakkai Zasshi; 1987 Nov; 76(11):1695-700. PubMed ID: 3151075
[No Abstract] [Full Text] [Related]
10. Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients.
McDonell KE; Preheim BA; Diedrich A; Muldowney JAS; Peltier AC; Robertson D; Biaggioni I; Shibao CA
J Clin Hypertens (Greenwich); 2019 Sep; 21(9):1308-1314. PubMed ID: 31368635
[TBL] [Abstract][Full Text] [Related]
11. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension.
Keating GM
Drugs; 2015 Feb; 75(2):197-206. PubMed ID: 25559422
[TBL] [Abstract][Full Text] [Related]
12. [Improvement in cardiovascular autonomic dysfunction of a patient with OPCA with L-threo-3,4-dihydroxyphenylserine].
Fukuma A; Matsubayashi K; Kitazumi T; Otsuka K; Sadakane N; Shimada K; Ozawa T
Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):847-51. PubMed ID: 3147311
[No Abstract] [Full Text] [Related]
13. The treatment of orthostatic hypotension with dihydroxyphenylserine.
Freeman R; Landsberg L
Clin Neuropharmacol; 1991 Aug; 14(4):296-304. PubMed ID: 1913697
[TBL] [Abstract][Full Text] [Related]
14. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
Azuma T; Suzuki T; Mizuno R; Tsujino S; Kishimoto S; Mizuta E; Ichikawa K
Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
[TBL] [Abstract][Full Text] [Related]
15. Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension.
Vernino S; Lew M; Kremens D
Clin Auton Res; 2017 Jul; 27(Suppl 1):35-37. PubMed ID: 28623420
[No Abstract] [Full Text] [Related]
16. Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
Claassen D; Lew M
Clin Auton Res; 2017 Jul; 27(Suppl 1):13-14. PubMed ID: 28631224
[No Abstract] [Full Text] [Related]
17. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.
Biaggioni I; Arthur Hewitt L; Rowse GJ; Kaufmann H
BMC Neurol; 2017 May; 17(1):90. PubMed ID: 28494751
[TBL] [Abstract][Full Text] [Related]
19. Neurogenic orthostatic hypotension: new prospects in treatment. Introduction.
Kaufmann H
Clin Auton Res; 2008 Mar; 18 Suppl 1():1. PubMed ID: 18368299
[No Abstract] [Full Text] [Related]
20. [Diabetic orthostatic hypotension].
Uchida K; Himei H
Nihon Rinsho; 1991 Feb; 49 Suppl():313-5. PubMed ID: 2033821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
